These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28730656)

  • 1. Spontaneous pregnancy during ulipristal acetate treatment of giant uterine leiomyoma.
    Hrgovic Z; Habek D; Cerkez Habek J; Hrgovic I; Jerkovic Gulin S; Gulin D
    J Clin Pharm Ther; 2018 Feb; 43(1):121-123. PubMed ID: 28730656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology.
    Rozenberg S; Praet J; Pazzaglia E; Gilles C; Manigart Y; Vandromme J
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):393-399. PubMed ID: 28567743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids.
    Garnock-Jones KP; Duggan ST
    Drugs; 2017 Oct; 77(15):1665-1675. PubMed ID: 28900897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulipristal acetate for uterine fibroid-related symptoms.
    Puchar A; Luton D; Koskas M
    Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulipristal, a progesterone receptor antagonist as a contraceptive and for the treatment of uterine fibroids.
    Orihuela PA
    Curr Opin Investig Drugs; 2007 Oct; 8(10):859-66. PubMed ID: 17907063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
    Donnez J; Donnez O; Dolmans MM
    Expert Opin Drug Saf; 2016 Dec; 15(12):1679-1686. PubMed ID: 27740868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology].
    Brazert M; Korman MP; Pawelczyk LA
    Ginekol Pol; 2013 Sep; 84(9):794-800. PubMed ID: 24191519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulipristal acetate: contraceptive or contragestive?
    Keenan JA
    Ann Pharmacother; 2011 Jun; 45(6):813-5. PubMed ID: 21666088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids.
    Luyckx M; Squifflet JL; Jadoul P; Votino R; Dolmans MM; Donnez J
    Fertil Steril; 2014 Nov; 102(5):1404-9. PubMed ID: 25241376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The molecular mechanisms and morphological manifestations of leiomyoma reduction induced by selective progesterone receptor modulators].
    Demura TA; Revazova ZV; Kogan EA; Adamyan LV
    Arkh Patol; 2017; 79(3):19-26. PubMed ID: 28631712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
    Pourcelot AG; Capmas P; Fernandez H
    J Gynecol Obstet Hum Reprod; 2017 Mar; 46(3):249-254. PubMed ID: 28403922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.
    Talaulikar VS; Manyonda I
    Womens Health (Lond); 2014 Nov; 10(6):565-70. PubMed ID: 25482483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulipristal acetate versus placebo for fibroid treatment before surgery.
    Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
    N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulipristal acetate and liver-injuries: while Esmya is revoked, EllaOne is allowed in repeated self-administrations possibly exceeding UPA toxic-dosing with Esmya.
    Mozzanega B
    J Hepatol; 2021 Mar; 74(3):750-751. PubMed ID: 33271158
    [No Abstract]   [Full Text] [Related]  

  • 15. Ulipristal acetate as an emergency contraceptive agent.
    Martinez AM; Thomas MA
    Expert Opin Pharmacother; 2012 Sep; 13(13):1937-42. PubMed ID: 22770536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial Effects of Prolonged Therapy with the Selective Progesterone Receptor Modulator Ulipristal Acetate: A Case Report.
    Levy G; Elkas J; Armstrong AY; Nieman LK
    J Reprod Med; 2016; 61(3-4):159-62. PubMed ID: 27172639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids.
    Tafi E; Scala C; Leone Roberti Maggiore U; Bizzarri N; Candiani M; Venturini PL; Ferrero S
    Expert Opin Drug Saf; 2015 Jun; 14(6):965-77. PubMed ID: 25772793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulipristal acetate for emergency contraception.
    Snow SE; Melillo SN; Jarvis CI
    Ann Pharmacother; 2011 Jun; 45(6):780-6. PubMed ID: 21666089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endometrial response to modulation of ligand-progesterone receptor pathways is reversible.
    Chodankar RR; Murray A; Nicol M; Whitaker LHR; Williams ARW; Critchley HOD
    Fertil Steril; 2021 Sep; 116(3):882-895. PubMed ID: 33865567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.